Although several important biomarkers, such as epidermal growth factor receptor (EGFR) mutation, have already been discovered, it is important to discover novel biomarkers of NSCLC to improve NSCLC detection [90,91]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.